Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 01 2023 - 8:30AM
Business Wire
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:
ELMD), a leader in innovative airway clearance technologies, today
announced that Jim Cunniff, President and Chief Executive Officer,
and Brad Nagel, Chief Financial Officer, are scheduled to attend
the Canaccord Genuity MedTech, Diagnostics and Digital Health &
Services Forum on November 16, 2023 at the Westin NY Grand Central
in New York City.
Electromed’s management team will engage in investor 1x1s on
Thursday, November 16, 2023.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that
provide airway clearance therapy, including the SmartVest® Airway
Clearance System, to patients with compromised pulmonary function.
It is headquartered in New Prague, Minnesota, and was founded in
1992. Further information about Electromed can be found at
www.smartvest.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231101778039/en/
Brad Nagel, Chief Financial Officer (952) 758-9299
investorrelations@electromed.com
Mike Cavanaugh, Investor Relations ICR Westwicke (617) 877-9641
mike.cavanaugh@westwicke.com
Electromed (AMEX:ELMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Electromed (AMEX:ELMD)
Historical Stock Chart
From Apr 2023 to Apr 2024
